David Roblin
Chief Executive Officer
Our team
Our interdisciplinary approach brings together the best from techbio, pharma, academia and venture — all working towards one common goal.
Chief Executive Officer
Chief Science Officer
Chief Technology Officer
Chief Operating Officer
SVP Growth & Operations
Chief Innovation Officer
Chair
DeepMind Professor of AI, University of Oxford
Professor, MIT and Co-director of The Eric & Wendy Schmidt Center, The Broad Institute
J. W. Kieckhefer Professor, Department of Chemistry, MIT
Chief Data Officer, Seer
Professor of Genome Biology, ETH Zurich and Co-founder, Spotlight Therapeutics
Professor of Clinical Epidmiology, University of Bristol
Professor of Genetics, Stanford University
Director, MRC Biostatistics Unit and Professor of Biostatistics, University of Cambridge
Associate Professor of Medicine, Mass. Gen. Hospital and Harvard Medical School
Reader in Translational Skeletal Research, University of London
Chief Executive Officer, Relation
Chair, Relation
General Partner, DCVC
Managing Partner, Magnetic Ventures
Managing Partner, DCVC
Partner, Khosla Ventures
Deputy-chair, Juvenescece
Chief Innovation Officer, Relation
Chief Operating Officer, Relation
Investment Director at NVentures
Principal at Hitachi Ventures
Learn how we’re discovering novel medicines for patients in need.